Table 1 Schedule and dose of treatment

From: Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial

IL-2

*

*

⋄

⋄

⋄

*

*

⋄

⋄

⋄

 

IFNα

#

 

#

 

#

#

 

#

 

#

 

5-FU

φ

φ

φ

φ

φ

      

day

1

2

3

4

5

15

 

17

 

19

29

           

Second cycle

  1. =IL-2: 9 × 106 IU m−2 × 2, ⋄=IL-2: 9 × 106 IU m−2, #=IFNα: 6 × 106 IU, φ=5-FU 750 mg m−2.
Back to article page